Atlas Trials

Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer

Clinical trial NCT00923806 · TERMINATED

Trial details

NCT number
NCT00923806
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Cancer
Start date
2008-12-01
Primary completion
2011-11-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.